INTRODUCTION
Endometriosis is a benign gynecologic disease defined as the presence of functional endometrial glands and stromal outside the uterine cavity. The symptoms could be dysmenorrhea, dyspareunia, menstrual irregularities, and infertility. 1 There is also a general agreement that endometriosis is a pelvic inflammatory process with altered function of immune-related cells in the peritoneal environment. 2, 3 Many number of studies were conducted to support this concept, in peritoneal fluid there were increased number of activated macrophages that secrete various cytokines. 2 The various cytokines were suggested involved in the mechanism of progression and associated infertility. 4 Recently, it was reported that the level of various cytokines is also increased in the serum of patient with endometriosis even though there are still debates from the conflicting result of the studies. 5 From this finding, there was suggestion that endometriosis is related to systemic subclinical inflammation. Furthermore, we questioned whether those changes are significant enough to be used as non-invasive diagnostic tools. 6, 7 There is a response from the body to inflammation, in which there is an increase in various plasma protein, fibrinogen, haptoglobin, caeruloplasmin and C-reactive protein (CRP). 8 There are two methods commonly used for detecting the acute phase response-the erythrocyte sedimentation rate (ESR) and the more specific measurement of CRP concentration. ESR has been used since 1921, and became popular as a non-specific screening test for disease in the routine examination to all patients, especially in small laboratories and primary health clinics as it is cheap, easy to perform and does not require a power supply nor expensive equipment. 8 The gold standard for the diagnosis of endometriosis is laparoscopy. 1, 6 The severity of diseases is categorized according to the American Fertility Society classification, which classifieds the disease into four groups that represent minimal to severe disease. The stage of endometriosis is positively correlated with the degree of subfertility, but not with the degree of pelvic pain.
Development of a noninvasive diagnostic test for endometriosis would have a ground breaking affect on patient's quality of life, on the efficacy of available treatment, and on the cost of endometriosis. 5, 7 Many serum biomarkers were proposed for further study. One of the biomarker is CA-125, which have been researched for almost three decades. Serum CA-125 measurement is now a consolidated method for diagnosing this condition and almost routinely measured in endometriosis patient. However, its interpretation has posed a number of problems, particularly regarding its use in diagnosing minimal and mild endometriosis, whereas its value as a diagnostic aid in moderate-severe stages is well recognized.
The purpose of this study was to see the profile of preoperative CA-125, ESR and CRP serum values in surgically treated endometriosis patient for various indication.
METHOD
From January to April 2012, we collected 40 patients who underwent laparoscopic surgery for endometriosis at Bunda hospital and YPK hospital, Jakarta. The diagnosis was made intraoperative based on the finding of endometriosis lesion or endometrioma. Informed consent from the patients was obtained, and the ethical review board of University Indonesia approved the study. We collected the obstetric and gynecologic history and relevant medical history, clinical symptoms, preoperative serum CA-125, ESR and CRP levels. The assay CA-125, ESR and CRP levels were performed at least 1 day before surgery. The serum CA-125 was measured by chemiluminescent immunoassay by advia centaur; serum CRP was measured by immunoturbidimetrybycobasintegra; while ESR was measured manually with SRS 20. We used independent T test to detecting difference in mean serum CA-125 , ESR and CRP. We performed receiver operating characteristic (ROC) curve analysis to assess the clinical utility of serum biomarker in distinguishing severe-moderate and minimal mild patient. The cutoff values derived from ROC curves were evaluated in terms of sensitivity and specificity.
RESULT
There were 40 subjects in this study that were classified according to the Revised American Study for Reproductive Medicine endometriosis classification. Twenty six subjects had minimal-mild and fourteen subjects had moderate-severe endometriosis. The distribution of age, BMI, and smoking in both group are similar. Minimal-mild endometriosis subjects had 88% infertility compared to 57% in moderate-severe subjects. The level of serum ESR, CRP and CA-125 did not have normal distribution. We transform the data into logarithmic to have normal distribution for independent T test calculation. Serum CA-125 could discriminate endometriosis stage I-II from stage III-IV with mean level 12.0 vs. 36.3 U/ml respectively (p=0.000). No difference was found for serum level ESR and CRP.
Indones J 122 Prayudhana et al Obstet Gynecol
| Serum CA-125 had AUC 87% (p < 0.001), meanwhile for serum ESR and CRP were 58% (p = 0.497) and 29% (p = 0.161) respectively. From the ROC curve analysis, we acquired that the optimal cut off point for serum level CA-125 to differentiate endometriosis stage I-II and III-IV was 16.9 U/ml. It has sensitivity 83% and specificity 81%. If the cut off point of CA-125 was >35 U/ml, the sensitivity was 67% and specificity 90%.
DISCUSSION
Women with endometriosis have been found to have elevated CA-125 levels in their serum, menstrual blood, and peritoneal fluid. However, the CA-125 level is not specific to endometriosis. This study demonstrates that preoperative CA-125 assay is useful to distinguish high-risk from low-risk endometriosis patients. Our results indicate a new use for preoperative serum CA-125 examination in addition to the diagnosis of endometriosis. The results confirm previous reports that preoperative CA-125 levels increase with the stages of endometriosis. 9 It further extends the observations that omentum adhesion and rupture of endometrioma are also the leading causes of elevated CA-125 levels. 9 Our study acquired a sensitivity of 83% and specificity of 81% for 16.9 U/ml as the optimal cut off point for CA-125. Silva et al got a slightly different cut-off point of 20 U/ml with 44.7% sensitivity and 92.2% specificity. 10 Cheng stated that CA-125 level was significantly higher in Table 2 . Bivariate analysis between ESR, CRP, and CA-125 with the severity of endometriosis. 10 Furthermore, serum CA-125 levels were significantly higher in patients with more extensive adhesions of the peritoneum, omentum, ovary, fallopian tube, colon, and cul-de-sac, or with ruptured endometrioma. Several authors claimed that its combination with transvaginal ultrasonography may help the differentiation of endometrioma from other benign ovarian cysts. 9 Patrelli stated that there was a relationship between the serum CA-125 values and the location of endometriosis foci, with higher elevations in ovarian and mixed forms than in extraovarian forms. 11 Although the pathogenesis of endometriosis is still controversial, growing evidence indicate a significant role of inflammatory factors involved in the development of endometriosis. 12, 13 Biomarker such as CRP and ESR are acute phase proteins that increased when inflammation occurs. It has been suggested that in women with endometriosis there is an inflammatory reaction of the pelvic peritoneum. Inflammation, as a local response to tissue injury, results in changes of vascular caliber, flow, and increased vascular permeability. The increasing level of CRP and ESR in pelvic peritoneum due to inflammation process can also be detected in blood serum. 12 However, measurement of CRP and ESR from our research did not appear to be advantageous for determining the severity of endometriosis. There was no association between CRP level and stage of the disease. Vodolazkaia reported different finding; he found statistically significant different median of CRP level between stage I-II and stage III-IV of endometriosis.
CONCLUSION
The CA-125 serum level was increased for moderate-severe endometriosis compared to minimal and mild endometriosis patient. The optimal cut off point for serum level CA-125 to differentiate between endometriosis stage I-II and III-IV is 16.9 U/ml, with 83% sensitivity and 81% specificity.
